Agripal is developed by Korea University Guro Hospital.

What development phase is Agripal in?

Agripal is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Agripal

Korea University Guro Hospital · FDA-approved active Biologic Quality 1/100

At a glance

Generic name	Agripal
Sponsor	Korea University Guro Hospital
Modality	Biologic
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Conventional Vaccine and Intradermal Vaccine Among HIV-infected Young Subjects (PHASE4)
Cell Immunity Response to Vaccination Against Influenza in Patients With Rheumatoid Arthritis (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Agripal CI brief — competitive landscape report
Agripal updates RSS · CI watch RSS
Korea University Guro Hospital portfolio CI